Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Simplified Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line Helicobacter Pylori Eradication
Conditions
Interventions
Vonoprazan 20 mg twice daily + clarithromycin 500 mg twice daily for 14 days
Start Date
February 24, 2026
Primary Completion Date
February 13, 2027
Completion Date
February 13, 2027
Last Updated
February 27, 2026
NCT07537634
NCT07516262
NCT07335406
NCT07179159
NCT07293910
NCT07358130
Lead Sponsor
Peking University First Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions